Text Size

Optimized Programming in Spinal Cord Stimulation (SCS) System (OP)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Boston Scientific Corporation
ClinicalTrials.gov Identifier:
NCT00871819
First received: March 27, 2009
Last updated: May 14, 2012
Last verified: May 2012
History of Changes
  Purpose

The objective of this study is to evaluate extent, location, and perception of paresthesia as a function of anode/cathode configuration.


Condition Intervention Phase
Neuropathic Pain
Pain
 Device: Precision Spinal Cord Stimulation (SCS)
 Phase 4

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Supportive Care
Official Title: Optimized Programming in a Multiple-Independent Current Sources Spinal Cord Stimulation (SCS) System

Further study details as provided by Boston Scientific Corporation:

Primary Outcome Measures:
  • Correlation Coefficient Between Dorsal Root Paresthesia (Total Pixels Derived From Digital Drawing) at Maximum-comfortable Stimulation Level and Anode-cathode Separation Distance (mm) [ Time Frame: Immediately post-procedure ] [ Designated as safety issue: No ]

Enrollment: 20
Study Start Date: March 2009
Study Completion Date: September 2009
Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Spinal Cord Stimulation Group
Spinal Cord Stimulation (SCS) Treatment Group
 Device: Precision Spinal Cord Stimulation (SCS)
Various SCS device programming parameters
Other Name: Precision Spinal Cord Stimulation System

Detailed Description:

The clinical results from this study may help to validate predictions made by mathematical models of neurons that are activated by SCS and increase scientific knowledge about the way in which different programs relate to satisfactory outcomes, such that use of the model may help in the development of new products.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Be previously implanted with Precision SCS System (3-36 months post permanent implant) having 2 parallel percutaneous leads placed between T8-T10.
  • Be implanted with Precision SCS System for the treatment of neuropathic pain of trunk and/or limbs
  • Be 18 years of age or older
  • Be extremely satisfied, very satisfied, or satisfied with SCS therapy for treatment of pain condition
  • Be able to use pen tablet to document regions of paresthesia and pain
  • Be able to lie in the supine position for 45 minutes at a minimum
  • Be able to verbally report qualitative and quantitative aspects of paresthesia sensations.
  • Have a paresthesia threshold on a standard program below 4mA while in the supine position
  • Have at minimum the upper contact of one lead below T8 and the lower contact above T11 vertebral levels
  • Be willing and able to comply with study-related procedure
  • Agree to study requirements and provides written Informed Consent

Exclusion Criteria:

  • Unable to read, write, speak, and understand English
  • Currently pregnant or planning to become pregnant during the course of the study
  • Have negative finding in any of the pre-screening and screening requirements
  • Upon fluoroscopy, location of both leads is identified to be outside T8-T10 vertebral levels
  • Unable to perceive the sensation of paresthesia associated with stimulation in the trunk and/or lower extremities
  • Have a drug pump and/or a non-Precision neurostimulation device (regardless of whether active or inactive)
  • Have had any interventional pain procedure or surgeries (including Interlaminar epidural steroid injection, Transforaminal epidural steroid injection, Caudal epidural steroid injection, Selective nerve root block, Intraarticular lumbar facet injection, Sacroiliac joint injection, Piriformis muscle injection, Trochanteric bursa injection, Hip/knee joint injections, Medial branch block (innervates facet joint), Pulsed radiofrequency neurotomy medial branches, Pulsed radiofrequency dorsal root ganglion, Thermal (high temperature) radiofrequency neurotomy medial branches, Trigger point injections, and Botulinum toxin injections) involving the spine within the past 30 days
  • Have any condition that is likely to confound evaluation of study endpoints. Conditions that may make paresthesia coverage variable over the course of the study include multiple sclerosis, partial spinal cord injury, diabetic peripheral neuropathy, peripheral vascular disease, scoliosis, deafferentation, etc.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00871819

Locations
United States, California
University of California, San Diego Medical Center
San Diego, California, United States, 92037
Sponsors and Collaborators
Boston Scientific Corporation
Investigators
Principal Investigator: Nicholas Kormylo, MD University of California, San Diego
  More Information

No publications provided

Responsible Party: Boston Scientific Corporation
ClinicalTrials.gov Identifier: NCT00871819     History of Changes
Other Study ID Numbers: A2008
Study First Received: March 27, 2009
Results First Received: February 13, 2012
Last Updated: May 14, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Boston Scientific Corporation:
Spinal Cord Stimulation

Additional relevant MeSH terms:
Neuralgia
Pain
Neurologic Manifestations
Nervous System Diseases
 Peripheral Nervous System Diseases
Neuromuscular Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on May 23, 2013